Product Information

RUFINAMIDE 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.9604 per EA under NDC 59651061608. Its NADAC has been published 164 times since Sep 6, 2023.

FDA first approved this application on Jun 16, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RUFINAMIDE 200 MG TABLET

rufinamide
$0.9604per EA

Strength

200 mg/1

NDC

59651061608

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RUFINAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217230

FDA Approved

6/16/2023

TE Code

AB

On Market Since

6/16/2023

Price Statistics

The NADAC for RUFINAMIDE 200 MG TABLET has been published 164 times since Sep 6, 2023, and over the history we have for it it has declined 59.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9604 per EA
All-time high$2.3971 (Sep 13, 2023)
All-time low$0.8320 (Aug 19, 2026)
52-week high$1.0788
52-week low$0.8320
Median price$1.4702
Average price$1.4276
Largest weekly change-14.2% (Nov 19, 2025)
Weeks tracked164
Tracking sinceSep 6, 2023

Price History

1W

+3.9%

1M

+9.0%

3M

+15.4%

6M

+1.3%

1Y

-11.0%

3Y

-54.6%

5Y

N/A

All

-59.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RUFINAMIDE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.9604 per EA (NDC 59651061608), effective Nov 18, 2026.

How has the price of RUFINAMIDE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for RUFINAMIDE 200 MG TABLET has declined 59.9%. It has been tracked across 164 weekly CMS publications since Sep 6, 2023.

What are the highest and lowest recorded NADAC prices for RUFINAMIDE 200 MG TABLET?

Since Sep 6, 2023, the NADAC for RUFINAMIDE 200 MG TABLET has ranged from a low of $0.8320 (Aug 19, 2026) to a high of $2.3971 (Sep 13, 2023), with a median of $1.4702 per EA.

Are there cheaper alternatives to RUFINAMIDE 200 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RUFINAMIDE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RUFINAMIDE 200 MG TABLET?

RUFINAMIDE 200 MG TABLET (NDC 59651061608) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.